Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 17

1.

Analysis of topographical distribution of prostate cancer and related pathological findings in prostatectomy specimens using cMDX document architecture.

Eminaga O, Semjonow A, Eltze E, Bettendorf O, Schultheis A, Warnecke-Eberz U, Akbarov I, Wille S, Engelmann U.

J Biomed Inform. 2015 Dec 17. pii: S1532-0464(15)00289-0. doi: 10.1016/j.jbi.2015.12.009. [Epub ahead of print]

PMID:
26707451
2.

Age-stratified cut-off points for the nocturnal penile tumescence measurement using Nocturnal Electrobioimpedance Volumetric Assessment (NEVA® ) in sexually active healthy men.

Tok A, Eminaga O, Burghaus L, Herden J, Akbarov I, Engelmann U, Wille S.

Andrologia. 2015 Oct 25. doi: 10.1111/and.12492. [Epub ahead of print]

PMID:
26498135
3.

Does postoperative radiation therapy impact survival in non-metastatic sarcomatoid renal cell carcinoma? A SEER-based study.

Eminaga O, Akbarov I, Wille S, Engelmann U.

Int Urol Nephrol. 2015 Oct;47(10):1653-63. doi: 10.1007/s11255-015-1093-y. Epub 2015 Sep 2.

PMID:
26329746
4.

Preoperative Serum Prostate-Specific Antigen Levels Vary According to the Topographical Distribution of Prostate Cancer in Prostatectomy Specimens.

Eminaga O, Hinkelammert R, Abbas M, Wötzel F, Eltze E, Bettendorf O, Boegemann M, Semjonow A.

Urology. 2015 Oct;86(4):798-804. doi: 10.1016/j.urology.2015.07.029. Epub 2015 Aug 6.

PMID:
26255036
5.

Treatment of Incidental Prostate Cancer by Active Surveillance: Results of the HAROW Study.

Herden J, Eminaga O, Wille S, Weissbach L.

Urol Int. 2015;95(2):209-15. doi: 10.1159/000431024. Epub 2015 May 30.

PMID:
26044747
6.

[Prediction of overactive bladder treatment outcome by using long-term urodynamics].

Wille S, Tenholte D, Cornely OA, Muthen N, Engelmann UH, Mehner J, Eminaga O, Herden J, Schumacher P, Paas J.

Urologe A. 2014 Dec;53(12):1812-4. doi: 10.1007/s00120-014-3629-7. German.

PMID:
25406371
7.

Preoperative prostate-specific antigen isoform p2PSA ≤ 22.5 pg/ml predicts advanced prostate cancer in patients undergoing radical prostatectomy.

Eminaga O, Bögemann M, Breil B, Titze U, Wötzel F, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Nov;32(8):1317-26. doi: 10.1016/j.urolonc.2014.04.018. Epub 2014 Jun 2.

PMID:
24893699
8.

Catheterless long-term ambulatory urodynamic measurement using a novel three-device system.

Wille S, Schumacher P, Paas J, Tenholte D, Eminaga O, Müller U, Muthen N, Mehner J, Cornely O, Engelmann U.

PLoS One. 2014 May 19;9(5):e96280. doi: 10.1371/journal.pone.0096280. eCollection 2014.

9.

Is there an urban-rural-gradient in patients with urinary incontinence?

Wille S, Katarzyna K, Ahrens U, Eminaga O, Engelmann U, Jenny P.

Can Urol Assoc J. 2014 Mar-Apr;8(3-4):E126-31. doi: 10.5489/cuaj.1488.

10.

Prostate cancers detected on repeat prostate biopsies show spatial distributions that differ from those detected on the initial biopsies.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Wötzel F, Bögemann M, Semjonow A.

BJU Int. 2015 Jul;116(1):57-64. doi: 10.1111/bju.12691. Epub 2015 Apr 17.

PMID:
24552505
11.

Tumor percentage but not number of tumor foci predicts disease-free survival after radical prostatectomy especially in high-risk patients.

Hinkelammert R, Eminaga O, Bettendorf O, Eltze E, Abbas M, Hertle L, Semjonow A.

Urol Oncol. 2014 May;32(4):403-12. doi: 10.1016/j.urolonc.2013.10.001. Epub 2013 Dec 12.

PMID:
24332639
12.

An electronic specimen collection protocol schema (eSCPS). Document architecture for specimen management and the exchange of specimen collection protocols between biobanking information systems.

Eminaga O, Semjonow A, Oezguer E, Herden J, Akbarov I, Tok A, Engelmann U, Wille S.

Methods Inf Med. 2014;53(1):29-38. doi: 10.3414/ME13-01-0035. Epub 2013 Dec 9.

PMID:
24317441
13.

Linkage of data from diverse data sources (LDS): a data combination model provides clinical data of corresponding specimens in biobanking information system.

Eminaga O, Özgür E, Semjonow A, Herden J, Akbarov I, Tok A, Engelmann U, Wille S.

J Med Syst. 2013 Oct;37(5):9975. doi: 10.1007/s10916-013-9975-y. Epub 2013 Sep 11.

PMID:
24022214
14.

High-grade prostatic intraepithelial neoplasia (HGPIN) and topographical distribution in 1,374 prostatectomy specimens: existence of HGPIN near prostate cancer.

Eminaga O, Hinkelammert R, Abbas M, Titze U, Eltze E, Bettendorf O, Semjonow A.

Prostate. 2013 Jul;73(10):1115-22. doi: 10.1002/pros.22660. Epub 2013 Mar 26.

PMID:
23532797
15.

The presence of positive surgical margins in patients with organ-confined prostate cancer results in biochemical recurrence at a similar rate to that in patients with extracapsular extension and PSA ≤ 10 ng/ml.

Eminaga O, Hinkelammert R, Titze U, Abbas M, Eltze E, Bettendorf O, Semjonow A.

Urol Oncol. 2014 Jan;32(1):32.e17-25. doi: 10.1016/j.urolonc.2012.11.021. Epub 2013 Feb 19.

PMID:
23434425
16.

CMDX©-based single source information system for simplified quality management and clinical research in prostate cancer.

Eminaga O, Abbas M, Hinkelammert R, Titze U, Bettendorf O, Eltze E, Ozgür E, Semjonow A.

BMC Med Inform Decis Mak. 2012 Dec 3;12:141. doi: 10.1186/1472-6947-12-141.

17.

Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens.

Eminaga O, Hinkelammert R, Semjonow A, Neumann J, Abbas M, Koepke T, Bettendorf O, Eltze E, Dugas M.

BMC Med Inform Decis Mak. 2010 Nov 15;10:71. doi: 10.1186/1472-6947-10-71.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk